Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

Tim Harrison, Pascal Chanez, Francesco Menzella, Giorgio Walter Canonica, Renaud Louis, Borja G. Cosío, Njira Lugogo, Arjun Mohan, Annie Burden, Lawrence McDermott,

The Lancet Respiratory Medicine · 2020 · 175 citations · 42 references

DOIFull text

Open access

Concepts

References

42